332 related articles for article (PubMed ID: 9370235)
21. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways.
Pal S; Claffey KP; Dvorak HF; Mukhopadhyay D
J Biol Chem; 1997 Oct; 272(44):27509-12. PubMed ID: 9346879
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.
Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z
Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.
Chan CC; Collins AB; Chew EY
Retina; 2007 Jan; 27(1):1-7. PubMed ID: 17218907
[TBL] [Abstract][Full Text] [Related]
24. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
[TBL] [Abstract][Full Text] [Related]
25. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
26. Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma.
Kruizinga RC; van Marion DM; den Dunnen WF; de Groot JC; Hoving EW; Oosting SF; Timmer-Bosscha H; Derks RP; Cornelissen C; van der Luijt RB; Links TP; de Vries EG; Walenkamp AM
Fam Cancer; 2016 Oct; 15(4):607-16. PubMed ID: 26920352
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M
Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148
[TBL] [Abstract][Full Text] [Related]
28. Expression of vascular endothelial growth factor in von Hippel-Lindau syndrome-associated papillary cystadenoma of the epididymis.
Leung SY; Chan AS; Wong MP; Yuen ST; Fan YW; Chung LP
Hum Pathol; 1998 Nov; 29(11):1322-4. PubMed ID: 9824115
[TBL] [Abstract][Full Text] [Related]
29. Von Hippel-Lindau disease.
Sano T; Horiguchi H
Microsc Res Tech; 2003 Feb; 60(2):159-64. PubMed ID: 12539169
[TBL] [Abstract][Full Text] [Related]
30. Expression of growth factors and growth factor receptors in capillary hemangioblastoma.
Böhling T; Hatva E; Kujala M; Claesson-Welsh L; Alitalo K; Haltia M
J Neuropathol Exp Neurol; 1996 May; 55(5):522-7. PubMed ID: 8627342
[TBL] [Abstract][Full Text] [Related]
31. Tumor derived vasculogenesis in von Hippel-Lindau disease-associated tumors.
Zhuang Z; Frerich JM; Huntoon K; Yang C; Merrill MJ; Abdullaev Z; Pack SD; Shively SB; Stamp G; Lonser RR
Sci Rep; 2014 Feb; 4():4102. PubMed ID: 24531117
[TBL] [Abstract][Full Text] [Related]
32. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.
Hatva E; Böhling T; Jääskeläinen J; Persico MG; Haltia M; Alitalo K
Am J Pathol; 1996 Mar; 148(3):763-75. PubMed ID: 8774132
[TBL] [Abstract][Full Text] [Related]
33. VHL-deficient vasculogenesis in hemangioblastoma.
Gläsker S; Smith J; Raffeld M; Li J; Oldfield EH; Vortmeyer AO
Exp Mol Pathol; 2014 Apr; 96(2):162-7. PubMed ID: 24394472
[TBL] [Abstract][Full Text] [Related]
34. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
35. Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization.
Wang Y; Chen DQ; Chen MY; Ji KY; Ma DX; Zhou LF
Sci Rep; 2017 Jul; 7(1):5463. PubMed ID: 28710479
[TBL] [Abstract][Full Text] [Related]
36. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
37. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
[TBL] [Abstract][Full Text] [Related]
38. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW
J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390
[TBL] [Abstract][Full Text] [Related]
39. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor.
Baba M; Hirai S; Yamada-Okabe H; Hamada K; Tabuchi H; Kobayashi K; Kondo K; Yoshida M; Yamashita A; Kishida T; Nakaigawa N; Nagashima Y; Kubota Y; Yao M; Ohno S
Oncogene; 2003 May; 22(18):2728-38. PubMed ID: 12743597
[TBL] [Abstract][Full Text] [Related]
40. Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease.
Los M; Aarsman CJ; Terpstra L; Wittebol-Post D; Lips CJ; Blijham GH; Voest EE
Ann Oncol; 1997 Oct; 8(10):1015-22. PubMed ID: 9402176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
